Reid G. Adler - 30 Jun 2025 Form 4 Insider Report for Vistagen Therapeutics, Inc. (VTGN)

Role
Chief Legal Officer
Signature
/s/ Cynthia Anderson, Attorney-in-Fact
Issuer symbol
VTGN
Transactions as of
30 Jun 2025
Net transactions value
+$12,820
Form type
4
Filing time
01 Jul 2025, 17:50:42 UTC
Previous filing
25 Jun 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Adler Reid G. Chief Legal Officer C/O VISTAGEN THERAPEUTICS, INC., 343 ALLERTON AVENUE, SOUTH SAN FRANCISCO /s/ Cynthia Anderson, Attorney-in-Fact 01 Jul 2025 0001924908

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VTGN Common Stock Award $12,820 +7,541 +46% $1.70 24,050 30 Jun 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person is voluntarily reporting the acquisition of shares under the Issuer's 2019 Employee Stock Purchase Plan, as amended, in a transaction exempt under Rule 16b-3(c) and Rule 16b-3(d).